ARCHIVES

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Bush Budget Reinforces Funding Trends, Reports Say.

July 13, 2001

Report Finds NIH Not At Fault in Case Of P-32 Ingestion

September 26, 1997

Two Breast Cancer Screening Methods Found Equivalent

August 29, 2008

AIDs Concepts Totaling $13 Million Approved By DCT Board; Will Be Funded By Special Appropriations

October 11, 1985

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 23, 1998

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009